for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Brazil's health regulator allows resumption of Chinese vaccine trial

BRASILIA, Nov 11 (Reuters) - Brazil’s health regulator Anvisa announced on Wednesday the resumption of clinical Phase III trials for China’s Sinovac COVID-19 vaccine.

Anvisa on Monday suspended trials of the Sinovac vaccine after the death of a volunteer registered as a suicide. (Reporting by Anthony Boadle; editing by Stephen Eisenhammer)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up